Trial · NCT06020456
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Comparison of the post-DDAVP FVIII peak in patients of the group "Null variants" vs "No Null variants" | FVIII levels 30-60 minutes after the DDAVP infusion | Factor VIII levels measured with a chronometric one stage-assay 30 or 60 minutes after the DDAVP infusion |
| Primary | Comparison of the post-DDAVP FVIII recovery in patients of the group "Null variants" vs "No Null variants" | FVIII levels before and 30-60 minutes after the DDAVP infusion | Factor VIII levels measured with a chronometric one stage-assay before (basal FVIII) the DDAVP infusion and 30 or 60 minutes after (FVIII peak). The FVIII recovery = ratio FVIII peak / basal FVIII |
| Primary | Comparison of the post-DDAVP FVIII clearance in patients of the group "Null variants" vs "No Null variants" | Factor VIII levels were measured until 24 hours after the desmopressin infusion | Factor VIII levels measured with a chronometric one stage-assay before and after DDAVP until 24h post-infusion |
| Primary | Comparison of the post-DDAVP FVIII area under the curve (AUC) in patients of the group "Null variants" vs "No Null variants" | Factor VIII levels were measured until 24 hours after the desmopressin infusion | Factor VIII levels measured with a chronometric one stage-assay before and after DDAVP until 24h post-infusion |
| Primary | Comparison of the post-DDAVP duration with FVIII normalized above 0.5 IU.dL-1 in patients of the group "Null variants" vs "No Null variants" | Factor VIII levels were measured until 24 hours after the desmopressin infusion | Factor VIII levels measured with a chronometric one stage-assay before and after DDAVP until 24h post-infusion |
| Primary | Comparison of the post-DDAVP duration with FVIII normalized above 0.8 IU.dL-1 in patients of the group "Null variants" vs "No Null variants" | Factor VIII levels were measured until 24 hours after the desmopressin infusion | Factor VIII levels measured with a chronometric one stage-assay before and after DDAVP until 24h post-infusion |
| Secondary | Influence of the age on the post-DDAVP FVIII peak | FVIII levels 30-60 minutes after the DDAVP infusion | factor VIII levels measured with a chronometric one stage-assay 30 or 60 minutes after the DDAVP infusion |
| Secondary | Influence of the age on the post-DDAVP FVIII recovery | FVIII levels before and 30-60 minutes after the DDAVP infusion | Factor VIII levels measured with a chronometric one stage-assay before (basal FVIII) the DDAVP infusion and 30 or 60 minutes after (FVIII peak). The FVIII recovery = ratio FVIII peak / basal FVIII |
| Secondary | influence of the age on the post-DDAVP FVIII area under the curve (AUC) | Factor VIII levels were measured until 24 hours after the desmopressin infusion | Factor VIII levels measured with a chronometric one stage-assay before (basal FVIII) the DDAVP infusion and 30 or 60 minutes after (FVIII peak). The FVIII recovery = ratio FVIII peak / basal FVIII |
| Secondary | influence of the age on the post-DDAVP duration with FVIII normalized above 0.5 IU.dL-1 | Factor VIII levels were measured until 24 hours after the desmopressin infusion | factor VIII levels measured with a chronometric one stage-assay before and after DDAVP until 24h post-infusion |
| Secondary | influence of the age on the post-DDAVP duration with FVIII normalized above 0.8 IU.dL-1 | Factor VIII levels were measured until 24 hours after the desmopressin infusion | factor VIII levels measured with a chronometric one stage-assay before and after DDAVP until 24h post-infusion |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06020456/registered